- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06492356
Impact of Tripolar Radiofrequency on Acne Scar
Study Overview
Status
Intervention / Treatment
Detailed Description
Acne scarring is a very troublesome complication associated with acne and is reported in as high as 95% of the patients, sometimes even with proper and prompt treatment. The visible depressed scars have been known to have a negative impact on patient's psychological well-being and quality of life. Post acne scarring can pose as a risk factor for depression, anxiety, and even suicide (Villani, 2020).
There are a multitude of treatment options that are traditionally used for the treatment of acne scars including many ablative and non-ablative methods (Dogra, 2014).
Furth more, the need of this study is developed from the lack in quantitative knowledge and information in the published studies which investigate the effect of tripollar RF This study will be designed to provide guidelines about the effect tripollar Radiofrequency on acne scars.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Minya, Egypt
- Malawy Specialized Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Forty patients having acne scar, from both genders their ages will be ranged from 20 to 40 years old
- Both genders will participate in this study as the following distribution 17 male and 23 female.
- They diagnosed as acne scar by their physicians and referred for physical therapy management.
- Medically and psychologically stable patients.
- All patients will approve and sign a consent form before starting the program which will include the purpose, natures and potential risks of the study which will be explained to all patients
Exclusion Criteria:
- Patients who suffer from hypertrophic and/or keloidal scars and a skin condition in the area of acne scars that would interfere with study procedures (e.g., plaque psoriasis, tattoo, birthmark, facial hair).
- Patients with medical red flags as severe psychiatric disorder or cognitive deficits.
- Medically unstable and uncooperative patients.
- Untreated and active/ongoing acne vulgaris.
- Immunocompromised status.
- History of skin cancer.
- Recurrent herpes viral infection.
- Pregnancy or breastfeeding status.
- Females take contraceptive pills
- Hormonal disturbance
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group A
Consists of 20 patients with acne scars and will receive medical treatment by a dermatologist and tripolar radiofrequency (RF) therapy once a week for 12 weeks, each session for 15 minutes.
|
Twenty patients underwent weekly TriPollar RF treatment, using a new RF technology with three or more electrodes.
Glycerin was applied to the treatment area before and after each session, with the procedure lasting 15 minutes.
The technology uses a sequence of electrical modulation to prevent overheating and requires no active cooling of the electrodes or skin.
Twenty patients will receive medical treatment by dermatologist.
|
|
Active Comparator: Group B
consists of 20 patients with acne scars and will receive medical treatment by a dermatologist
|
Twenty patients will receive medical treatment by dermatologist.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessing the change in severity of acne scars
Time Frame: at base line and following 12 weeks
|
SCARS is a 5-item instrument designed to rate the severity of acne scars in a mirror.
It uses visual analog scales to differentiate between active and scars.
The tool is self-completion and can be completed quickly.
Patients are photographed at the beginning and after 12 treatment sessions.
SCARS scores range from 0 to 4, with higher scores indicating greater severity.
It captures demographic information and clinical characteristics of acne and scarring.
|
at base line and following 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessing the quantitative measurement of the acne scars
Time Frame: at base line and following 12 weeks
|
Dey et al. developed an automatic approach to quantify acne scars using color images, achieving a sensitivity of 90.36 and specificity of 93.82.
However, this method does not allow for volumetric assessment of the scar.
Another technique, proposed by Petukhova et al., uses three-dimensional photographic images to construct a topographic map, which is then objectively calculated for each scar.
This method does not assess color changes like dyspigmentation, which is essential for tracking scars over time.
Further testing is needed to improve this method.
|
at base line and following 12 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Alshymaa M.sc
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Scar
-
University of California, DavisCompletedLinear Scar | Zigzag ScarUnited States
-
Capstone TherapeuticsCompletedScar Prevention | Scar ReductionUnited States
-
Wake Forest University Health SciencesCompleted
-
Medstar Health Research InstituteActive, not recruitingBurn Scar | Scar | Skin Graft ScarUnited States
-
Iran University of Medical SciencesRecruitingDry Needling | Scar Tissue | Hypertrophic Scar | Hypertrophic Surgical Scar | Hypertrophic Scar of Upper Arm (Disorder)United States, Iran, Islamic Republic of
-
University of PittsburghUnited States Department of DefenseTerminatedBurn Scar | Restrictive Scar Contracture | Restrictive Hypertrophic Scar | Burn Scar ContracturesUnited States
-
Maternal and Child Health Hospital of FoshanWithdrawn
-
Lumenis Be Ltd.Terminated
-
Riphah International UniversityRecruiting
-
CellinCellsNot yet recruiting
Clinical Trials on Tripolar radiofrequency therapy
-
CREmedicalBoston Children's Hospital; Barrow Neurological InstituteRecruiting
-
Adana City Training and Research HospitalNot yet recruiting
-
Ch Mont de MarsanCentre Hospitalier de DaxRecruiting
-
Diskapi Teaching and Research HospitalRecruitingPlantar Fasciitis | Spur, Heel | Chronic Plantar Heel PainTurkey (Türkiye)
-
Sohag UniversityNot yet recruitingCarpal Tunnel Syndrome (CTS)Egypt
-
University of Castilla-La ManchaNot yet recruitingGenitourinary Syndrome of Menopause (GSM)Spain
-
Sohag UniversityNot yet recruiting
-
Synaptrix, Inc.Recruiting
-
University Hospital, ToulouseCompletedPrimary Aldosteronism | Adrenal AdenomaFrance
-
Gaziler Physical Medicine and Rehabilitation Education...CompletedKnee OsteoarthritisTurkey (Türkiye)